At present, TOSP has approximately 250,000 sq ft of existing leased and managed buildings. Its 14.75 acres of development land has capacity to add a further 420,000 sq ft to support the growth of existing occupiers and enable new companies to join the thriving campus.
Rory Maw, Bursar at Magdalen College Oxford and Director of The Oxford Science Park, said: “Beyond its unrivalled strategic location, one of the key features of The Oxford Science Park’s success has been the ability of occupiers to scale up on site – with many starting out in incubator buildings before expanding into larger, dedicated facilities. Our role is to support the growth ambitions of existing occupiers, providing flexibility with their space requirements, and others wanting to join this unique and collaborative community. We believe a strategic partnership provides the most attractive mechanism to raise capital to accelerate the timetable for developing additional capacity to meet unprecedented demand and to further the discovery, innovation and entrepreneurship taking place at The Oxford Science Park.
Magdalen College has a tradition of academic excellence and entrepreneurship. The Park upholds the College’s heritage – many of its buildings and roads are named after its famous scientific alumni – and this next step in TOSP’s evolution develops this tradition further.”
Magdalen College is being advised in its search for a strategic partner by Cushman & Wakefield.
About The Oxford Science Park
The Oxford Science Park is owned and managed by Magdalen College, Oxford. Created in 1991, the Park upholds the College’s heritage and provides one of the most influential science & technology environments in the UK. There is high quality workspace accommodation across the Park, which is now home to 2,700 people and more than 130 businesses. These range from start-ups based in the Magdalen Centre innovation hub to major international companies and include Blue Earth Diagnostics, MiroBio, OrganOx, OxSonics Therapeutics, Oxford Nanopore Technologies, OXGENE, ProImmune, Oxford Sciences Innovation, Evox Therapeutics, Vaccitech, Exscientia, Sensyne Health and Intuitive Surgical.
In addition to being a key property investment, the Park is at the heart of Magdalen College’s strategy to support discovery, innovation and entrepreneurship. It will continue to develop The Oxford Science Park as a long-term strategic asset, with ambitious plans to create an additional 400,000+ sq ft of office and laboratory space on 14.75 acres of development land. This additional capacity will support the growth of businesses already based on the Park, providing flexible workspace accommodation, and enabling new companies to enjoy the Park’s exceptional environment and collegiate and collaborative ethos. The Oxford Science Park is located approximately four miles south-east of Oxford city centre, just off the City’s southern ring road. It has easy access to the M40 and A34, as well as to Heathrow Airport and mainline train services. For further information, please visit: www.oxfordsp.com or follow us on twitter @OxfordSciencePK